Tumor necrosis factor-α, sphingosine, ceramide: Which is the appropriate marker of inflammation?
- 1 November 1999
- journal article
- editorial
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 27 (11) , 2580-2581
- https://doi.org/10.1097/00003246-199911000-00048
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Tumor Necrosis Factor-α Provokes a Hypertrophic Growth Response in Adult Cardiac MyocytesCirculation, 1997
- Tumor Necrosis Factor Mediates Impaired Wound Healing in Chronic Abdominal SepsisThe Journal of Trauma: Injury, Infection, and Critical Care, 1997
- Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death.Journal of Clinical Investigation, 1996
- Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum.The Journal of Experimental Medicine, 1996
- Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration.Journal of Clinical Investigation, 1995
- A preliminary exploration of the relationship between Tumour Necrosis Factor (TNF) and monocytic in vitro production of interleukin-1 (IL-1) and internal organ dysfunction in severely burned patientsBurns, 1995
- Basic Mechanisms in Congestive Heart FailureChest, 1994
- TUMOR NECROSIS FACTOR: A Pleiotropic Cytokine and Therapuetic TargetAnnual Review of Medicine, 1994
- The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia.Journal of Clinical Investigation, 1992
- Shock and Tissue Injury Induced by Recombinant Human CachectinScience, 1986